Literature DB >> 8144684

Involvement of neurofilaments in motor neuron disease.

Z Xu1, L C Cork, J W Griffin, D W Cleveland.   

Abstract

Motor neuron disease is clinically characterized by progressive muscle wasting leading to total muscle paralysis. A long history of pathological study of patients has firmly established that the primary lesion site is in spinal and cortical motor neurons. In addition to the wide-spread loss of these neurons, neuronal abnormalities including massive accumulation of neurofilaments in cell bodies and proximal axons have been also widely observed, particularly in the early stages of the disease. To test whether high accumulation of neurofilaments directly contributes to the pathogenic process, transgenic mice that produce high levels of neurofilaments in motor neurons have been generated. These transgenic mice show most of the hallmarks observed in motor neuron disease, including swollen perikarya with eccentrically localized nuclei, proximal axonal swellings, axonal degeneration and severe skeletal muscle atrophy. These data indicate that extensive accumulation of neurofilaments in motor neurons can trigger a neurodegenerative process and may be a key intermediate in the pathway of pathogenesis leading to neuronal loss.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8144684     DOI: 10.1242/jcs.1993.supplement_17.15

Source DB:  PubMed          Journal:  J Cell Sci Suppl        ISSN: 0269-3518


  7 in total

1.  A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene.

Authors:  I V Mersiyanova; A V Perepelov; A V Polyakov; V F Sitnikov; E L Dadali; R B Oparin; A N Petrin; O V Evgrafov
Journal:  Am J Hum Genet       Date:  2000-06-07       Impact factor: 11.025

2.  Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant.

Authors:  L I Bruijn; M F Beal; M W Becher; J B Schulz; P C Wong; D L Price; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

3.  Electron tomographic analysis of cytoskeletal cross-bridges in the paranodal region of the node of Ranvier in peripheral nerves.

Authors:  Guy A Perkins; Gina E Sosinsky; Sassan Ghassemzadeh; Alex Perez; Ying Jones; Mark H Ellisman
Journal:  J Struct Biol       Date:  2007-10-22       Impact factor: 2.867

Review 4.  Intermediate filaments as dynamic structures.

Authors:  M W Klymkowsky
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

Review 5.  Transgenic and knockout mice in the study of neurodegenerative diseases.

Authors:  A Aguzzi; S Brandner; S Marino; J P Steinbach
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

6.  Nonphosphorylated neurofilament protein is expressed by scattered neurons in the vestibular and precerebellar brainstem.

Authors:  Joan S Baizer
Journal:  Brain Res       Date:  2009-09-01       Impact factor: 3.252

7.  Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport.

Authors:  Fatima Ferreirinha; Angelo Quattrini; Marinella Pirozzi; Valentina Valsecchi; Giorgia Dina; Vania Broccoli; Alberto Auricchio; Fiorella Piemonte; Giulia Tozzi; Laura Gaeta; Giorgio Casari; Andrea Ballabio; Elena I Rugarli
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.